Pfizer, BioNTech announce first ‘milestone’ Covid-19 vaccine
Pfizer and BioNTech vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised.
Accessibility Tools
Pfizer and BioNTech vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised.